Lissette Gomez-Rios
Acute Care · Miami, FLNPI 1609549591
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,756 and has fallen 61.3% since, to $679 in 2025. Among acute care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $102.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$512
- Genentech USA, Inc.$460
- Jazz Pharmaceuticals Inc.$436
- Pfizer$414
- Regeneron Healthcare Solutions, Inc.$357
- Amgen$304
- plus $3K from 20 others
What the payments were for
- Food & beverage$5,23398%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 5 | $512 |
| Genentech USA, Inc. | 4 | $460 |
| Jazz Pharmaceuticals Inc. | 4 | $436 |
| Pfizer | 4 | $414 |
| Regeneron Healthcare Solutions, Inc. | 3 | $357 |
| Amgen | 3 | $304 |
| AstraZeneca | 3 | $270 |
| E.r. Squibb & Sons, L.L.C. | 2 | $250 |
| Sobi, Inc | 2 | $238 |
| Sanofi | 2 | $238 |
| Eisai Inc. | 2 | $224 |
| Beigene USA, Inc. | 2 | $188 |
| Johnson & Johnson | 2 | $188 |
| Mirati Therapeutics, Inc. | 2 | $124 |
| GT Medical Technologies, Inc | 1 | $123 |
| Dendreon Pharmaceuticals LLC | 1 | $122 |
| GSK | 1 | $120 |
| Ipsen Biopharmaceuticals, Inc | 1 | $118 |
| Gilead | 1 | $116 |
| Sirtex Medical Inc | 1 | $113 |
| Sanofi-aventis U.S. LLC | 1 | $110 |
| Tactile Systems Technology Inc | 1 | $93 |
| Daiichi Sankyo Inc. | 1 | $92 |
| Bristol Myers Squibb | 1 | $81 |
| Exact Sciences | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,332 in reported general payments places this provider in the 95th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $201 |
Paid to pharmacies, not to this prescriber.
Other acute care in Miami
- Yvette NaranjoMiami$12K
- Yuri CarmonaMiami$10K
- Monica RamirezMiami$9K
- Rosa Canete-YohamMiami$9K
- Julio AcostaMiami$9K
- Uday DasariMiami$7K
- Julissa WilliamsMiami$7K
- Michelle ViteriMiami$6K
- Marie RenoitMiami$6K
- Rebecca JuliaoMiami$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.